Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge Vs. The Controller General of Patents, Designs and Trade Marks & Anr.
Date of Judgment: 17.06.2026
Case No.: IPDPTA/11/2024
Neutral Citation: Not Assigned
Court:
Hon'ble Judge:
The Court considered a dispute concerning the rejection of a patent application for alleged non-compliance with the disclosure requirements under the Patents Act, 1970. The case arose from allegations that the patent specification failed to sufficiently describe the invention, lacked clarity, omitted essential technical details, and did not disclose the source and geographical origin of the biological material used in the invention. The principal question before the Court was whether the Controller of Patents was justified in rejecting the patent application under Section 15 of the Patents Act for non-compliance with Section 10 of the Act.
After examining the material on record and the submissions of the parties, Justice Ravi Krishan Kapur observed that a patent applicant must make a complete, clear and enabling disclosure so that a person skilled in the art can perform the invention without undue experimentation. The Court held that the appellant's specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) of the Patents Act, emphasizing that omission to disclose the source and geographical origin of biological material and failure to provide sufficient technical disclosure are fatal defects in a patent specification.
Accordingly, the Court dismissed the appeal and upheld the Controller's order rejecting the patent application.
Disclaimer: Readers are advised not to treat this as a substitute for legal advice as it is based on limited information and is intended solely for general informational purposes.
Comprehensive Analytical Article
Introduction
The judgment delivered by the Intellectual Property Rights Division of the High Court at Calcutta is an important addition to Indian patent jurisprudence on the fundamental requirement of sufficiency of disclosure. The decision reiterates that the grant of a patent is a statutory monopoly available only in exchange for complete and meaningful disclosure of the invention to the public. The Court reaffirmed that vague descriptions, broad claim language, absence of workable examples and failure to disclose the source and geographical origin of biological material can justify refusal of patent protection.
The judgment is particularly significant for patent applicants, biotechnology companies, pharmaceutical innovators, research institutions and intellectual property professionals. It reinforces that patent specifications must not merely describe the desired result but must enable a person skilled in the relevant field to actually perform the invention. The decision also highlights India's commitment to preventing biopiracy by insisting upon compliance with statutory requirements relating to biological material.
Factual and Procedural Background
The appellant, Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge, filed Patent Application No. 202137013369 relating to an invention titled "Method for Stimulating the Growth of Biomass in a Liquid Inside a Bioreactor." The application was filed on 26 March 2021 and was subsequently examined by the Patent Office after a request for examination was submitted.
During examination, the Patent Office issued a First Examination Report pointing out that the complete specification did not comply with Section 10 of the Patents Act, 1970. According to the Patent Office, the specification lacked clarity, proper structure and sufficient disclosure. The applicant submitted amendments in response to the examination report in an attempt to overcome the objections.
Despite these amendments, the Controller of Patents remained unconvinced. A hearing notice was issued raising concerns regarding insufficiency of disclosure, lack of clarity, broad and indefinite claims and non-compliance with the statutory requirements governing patent specifications. Eventually, by an order dated 24 May 2024, the Controller rejected the application under Section 15 of the Patents Act.
Aggrieved by this rejection, the appellant preferred an appeal before the Intellectual Property Rights Division of the High Court at Calcutta. The appellant argued that the Controller had introduced fresh objections during the hearing without conducting a fresh examination and had incorrectly concluded that the specification failed to satisfy the statutory requirements. The appellant also contended that disclosure of the geographical origin of biological material was unnecessary because the invention did not claim the biological material itself.
The respondents defended the rejection by contending that the patent specification was fundamentally deficient. According to the respondents, it lacked sufficient technical disclosure, working examples, experimental parameters and necessary information regarding the biological material used in the invention. They also argued that the amended claims remained vague and incapable of enabling a skilled person to reproduce the invention without excessive experimentation.
Dispute Before the Court
The principal controversy before the Court was whether the Controller of Patents had correctly rejected the patent application for failing to comply with the mandatory disclosure requirements contained in Section 10 of the Patents Act, 1970.
The Court was also required to determine whether the specification adequately disclosed the invention, whether the absence of working examples and technical parameters rendered the claims insufficient, whether disclosure of the source and geographical origin of biological material was mandatory in the facts of the case, and whether the Controller had violated procedural safeguards by allegedly introducing new objections at the hearing stage.
The appellant maintained that the invention was sufficiently disclosed and capable of being worked by a person skilled in the relevant field without undue experimentation. It also argued that the Controller had misunderstood the specification and had taken isolated expressions out of context while assessing clarity.
The respondents, on the other hand, contended that the specification merely described desired outcomes without providing the technical information necessary for implementation. According to them, the omission of biological source information and the absence of enabling disclosure rendered the application fundamentally defective and incapable of receiving patent protection.
Comprehensive Analytical Article (Part 2)
Reasoning and Analysis of the Court
The Court undertook a detailed examination of Section 10 of the Patents Act, 1970, which prescribes the mandatory contents of a complete specification. It observed that every patent specification must fully and particularly describe the invention, explain its operation or use, disclose the best method known to the applicant for performing the invention, and conclude with claims that are clear, succinct and fairly based on the disclosure. These statutory requirements are not procedural formalities but constitute the foundation upon which the grant of a patent rests.
The Court emphasized that the doctrine of sufficiency of disclosure is one of the cornerstones of patent law. A patent grants the inventor a statutory monopoly, but such monopoly is justified only because the inventor, in return, contributes meaningful technical knowledge to the public. Consequently, the complete specification must enable a person ordinarily skilled in the relevant technical field to perform the invention without having to undertake further inventive work or excessive experimentation. Mere statements of desired results or broad theoretical concepts cannot satisfy this legal standard.
Applying these principles, the Court found significant deficiencies in the appellant's specification. Although the invention related to stimulating biomass growth in a bioreactor through irradiation, the specification failed to disclose essential operational parameters. It contained wide ranges of irradiation levels and time intervals without explaining how those parameters were to be selected or implemented in practice. Expressions such as "periodically", "at most", "maximum of", and "time interval" were considered too vague because they failed to define workable technical limits. The absence of experimental data, practical examples, or reproducible methodology meant that a skilled person would have to engage in extensive trial and error before successfully carrying out the invention. Such a disclosure, the Court held, fell short of the statutory requirement under Sections 10(4)(a), 10(4)(b), and 10(5) of the Patents Act.
Another significant aspect of the judgment concerned the disclosure of biological material. The appellant argued that disclosure of the source and geographical origin of biological material was unnecessary because the invention did not claim ownership over the biological material itself. The Court rejected this submission. It held that whenever biological material is used in an invention, the second proviso to Section 10(4)(d) expressly requires disclosure of its source and geographical origin. This requirement exists irrespective of whether the biological material itself is claimed as the invention. The statutory mandate serves important public policy objectives, including prevention of biopiracy, protection of India's biological resources, and compliance with the Biological Diversity Act, 2002 and the Convention on Biological Diversity. Consequently, failure to disclose the source and geographical origin of the microorganisms used in the invention constituted a serious defect that independently justified rejection of the application.
The Court also referred to the Guidelines for Examination of Patent Applications in the Field of Pharmaceuticals, particularly paragraphs 11.1 and 11.2, which reiterate that complete specifications involving biological material must contain sufficient disclosure and, where necessary, details of deposits under the Budapest Treaty together with the source and geographical origin of the biological material. The Court observed that although these Guidelines do not override the statute, they faithfully reflect the legislative requirements contained in Section 10 and therefore support a strict approach towards compliance.
While interpreting Section 10, the Court relied upon and discussed several judicial precedents. It referred to Farbwerke Hoechst A.G. v. Unichem Laboratories, AIR 1969 Bom 255, for the principle that a complete specification must enable a skilled person to perform the invention without further invention. The Court also relied upon Arti Srivastava v. Assistant Controller of Patents, C.A. (COMM.IPD-PAT) 252/2022 (Delhi High Court, decided on 11 May 2026), which reiterated the necessity of enabling disclosure. Further reliance was placed on The Regents of the University of California v. The Controller of Patents, 2025 SCC OnLine Del 987, and AGFA NV v. Assistant Controller of Patents and Designs, 2023 SCC OnLine Del 3493, both of which emphasized that inadequate disclosure and absence of sufficient technical particulars render a patent specification non-compliant with Section 10.
The appellant had relied upon the decision of the Supreme Court of the United Kingdom in Regeneron Pharmaceuticals Inc. v. Kymab Ltd., [2020] UKSC 27, arguing that the law does not require proof of every possible embodiment within the claimed range. The Court accepted the legal proposition in principle but held that the decision was distinguishable on facts. Unlike Regeneron, the present case did not involve a specification disclosing a general principle capable of practical implementation. Instead, the specification failed to provide the minimum technical information necessary for reproducing the invention, thereby compelling a skilled person to engage in undue experimentation. Consequently, the reliance placed upon Regeneron was held to be misplaced.
The Court also rejected the procedural challenge advanced by the appellant. It held that objections under Section 10 had already been communicated in the First Examination Report and were reiterated in the hearing notice. Since the amendments introduced by the appellant did not substantially alter the specification or remove the deficiencies, there was no legal requirement for a fresh examination under Sections 12, 13 or 14 of the Patents Act. The appellant had sufficient notice of the objections and adequate opportunity to respond. Therefore, there was neither violation of the principles of natural justice nor any procedural irregularity in the Controller's decision-making process.
The Court concluded with a broader observation regarding the philosophy of patent law. It reiterated that patents are intended to teach the public how to perform an invention. A patent specification that leaves critical aspects undisclosed, compels extensive experimentation, or merely describes functional outcomes without practical implementation cannot justify the grant of an exclusive statutory monopoly. The Court described the appellant's specification as effectively "empty" because it disclosed desired results without providing an enabling pathway for achieving them.
Final Decision of the Court
After considering the statutory framework, the rival submissions and the technical material on record, the Court found no illegality, perversity or procedural irregularity in the Controller's order rejecting the patent application.
The Court held that the patent specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) of the Patents Act, 1970. It also held that the omission to disclose the source and geographical origin of the biological material constituted an independent ground for refusal.
Accordingly, the appeal was dismissed, and the order dated 24 May 2024 passed by the Controller of Patents rejecting Patent Application No. 202137013369 under Section 15 of the Patents Act was affirmed.
Point of Law Settled
The judgment reinforces that compliance with Section 10 of the Patents Act, 1970 is mandatory and not merely procedural. A patent applicant must provide an enabling disclosure that permits a person skilled in the relevant art to perform the invention without undue experimentation. Broad claims unsupported by sufficient technical disclosure, absence of working examples, vague operational parameters, or failure to disclose the source and geographical origin of biological material will render a patent specification legally insufficient.
The decision also clarifies that disclosure of the source and geographical origin of biological material is mandatory whenever such material is used in an invention, irrespective of whether the biological material itself forms the subject matter of the patent claim. This judgment is likely to serve as an important precedent in biotechnology and pharmaceutical patent prosecutions by reaffirming the principle that exclusive patent rights are granted only in exchange for complete, clear and enabling disclosure.
Title of the Case: Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge v. The Controller General of Patents, Designs and Trade Marks & Anr.
Date of Judgment/Order: 17.06.2026
Case Number: IPDPTA/11/2024
Neutral Citation: Not Assigned
Name of Court: High Court at Calcutta
Name of Hon'ble Judge: Justice Ravi Krishan Kapur
Written By:Advocate Ajay Amitabh Suman, IP Adjutor [Patent and Trademark Attorney], High Court of Delhi
Disclaimer:Images used herein do not reflect actual images used in the Judgment and are intended solely for illustrative purposes. Readers are advised not to treat this article as a substitute for legal advice as it may contain errors in perception, interpretation, and presentation. The article is prepared for general informational and educational purposes only.
Suggested SEO Titles
1. Calcutta High Court Upholds Rejection of Patent for Insufficient Disclosure under Section 10 of the Patents Act
2. Patent Specification Must Enable Skilled Person: Calcutta High Court Clarifies Section 10 Requirements
3. Biological Material Disclosure Mandatory in Patent Applications: Calcutta High Court Judgment Explained
4. Fraunhofer v Controller General of Patents: Landmark Ruling on Sufficiency of Disclosure
5. Complete Disclosure is Essential for Patent Grant: Calcutta High Court IPD Decision
6. Patent Law Update 2026: Calcutta High Court on Enabling Disclosure and Biological Material
7. Section 10 of the Patents Act Explained through Fraunhofer Patent Case
8. Patent Rejection Upheld for Vague Claims and Inadequate Specification: High Court Analysis
9. Important Patent Judgment on Sufficiency of Disclosure and Biopiracy Compliance
10. Calcutta High Court Strengthens Patent Disclosure Standards under the Patents Act
11. Patent Drafting Lessons from Fraunhofer v Controller General of Patents
12. How Indian Courts Interpret Sufficiency of Disclosure in Patent Applications
Suggested SEO Tags
Patent Law India, Patents Act 1970, Section 10 Patents Act, Section 15 Patents Act, Patent Specification, Sufficiency of Disclosure, Enabling Disclosure, Patent Drafting, Patent Litigation India, Patent Prosecution, Intellectual Property Law, Biotechnology Patent, Biological Material Disclosure, Geographical Origin Biological Material, Patent Examination, Controller of Patents, Patent Appeal, Calcutta High Court IPD, Intellectual Property Rights Division, Patent Rejection, Patent Claims, Patent Law Update 2026, Biopiracy, Budapest Treaty, Patent Practice India, Indian Patent Law, Patent News India, Patent Attorney India, Patent Jurisprudence, AdvocateAjayAmitabhSuman, IPAdjutor
Headnote of the Judgment
Fraunhofer Gesellschaft Zur Forderung der Angewandten Forschunge v. The Controller General of Patents, Designs and Trade Marks & Anr., decided by the High Court at Calcutta (Intellectual Property Rights Division) in IPDPTA/11/2024, concerned an appeal challenging rejection of a patent application under Section 15 of the Patents Act, 1970. The Court held that the complete specification failed to satisfy the mandatory requirements of Sections 10(4) and 10(5) as it lacked enabling disclosure, working examples, clarity, and omitted disclosure of the source and geographical origin of the biological material used in the invention. Holding that patents can be granted only upon complete, clear and enabling disclosure, the Court dismissed the appeal and upheld the Controller's rejection of the patent application.
Info-Graphic Thumbnail Prompt
**Create a premium 3D hyper-realistic 8K legal infographic thumbnail in 14:9 aspect ratio depicting an advanced biotechnology laboratory with a futuristic bioreactor emitting subtle blue and amber illumination. Display a partially transparent patent specification document with highlighted technical diagrams, scientific formulae and claim sheets being examined under a glowing digital legal dashboard. Show realistic DNA strands, microscopic biological cells, laboratory glassware, radiation beams and holographic patent validation icons. Include a bold red "PATENT REJECTED" style stamp, broken patent seal, warning indicators and a metallic balance of justice to symbolise judicial scrutiny. Use premium black, deep red, metallic gold and silver colour palette with glowing amber highlights, cinematic lighting, realistic reflections, ultra-sharp textures, volumetric lighting and modern intellectual property aesthetics. Keep text extremely minimal using only phrases such as "Patent Rejected", "Section 10", and "Insufficient Disclosure". Avoid clutter. Use realistic 3D charts, legal dashboards, technical illustrations and visual storytelling instead of text-heavy graphics. Do not use the name of any Court, Judge, lawyer, national flag, Ashoka Emblem or any government insignia. Use generic legal and scientific imagery only. Use attached image as Image of lawyer in lawyers dress at left bottom corner which should cover 20% of entire image area.
